近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Lingchuan Guo, Weidong Zhu, Xiangyuan Ma, Hao Ni, Enjian Zhong, Yang W.Shao, Jie Yu, Dongmei Gu1, Shundong Ji, , Haodong Xu, Cheng Ji, Jinming Yang*, Yi Zhang*. Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer, Cancer Biol Ther, 2019;20(3):240-246.. *(Corresponding author)
2. Xiao-Hui Wang, Cheng Ji, Hong-Han Zhang, Yu Shan, Yi-Jie Ren, Yan-Wei Hu, Ling-Chuan Guo, Wei-Dong Zhu, Yu-Juan Xia1, Bei-Jia Liu, Zi-Yun Rong, Bi-Lian Wu, Zhi-Jun Ming, Jianxun Song, Jin-Ming Yang*, Yi Zhang*. Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents. J Biol Chem, 2019 Jun 21;294(25):10006-10017. *(Corresponding author)
3. Yu P, Wang HY, Tian M, Li AX, Chen XS, Wang XL, Zhang Y*, Cheng Y*. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro. Acta Pharmacol Sin. 2019 Mar 26. doi: 10.1038/s41401-019-0222-z. *(Corresponding author)
4. Cheng Ji, Qiong-Hua Xu, Ling-Chuan Guo, Yi-Jie Ren, Hong-Han Zhang, Wei-Dong Zhu, Zhi-Jun Ming, Yun-Sheng Yuan, Xin-Cong Ren, Yan Cheng, Jin-Ming Yang*, Yi Zhang*. eEF-2 Kinase-targeted miR-449b Confers Radiation Sensitivity to Cancer Cells, Cancer Lett, 2018, Apr 1;418:64-74. *(Corresponding author)
5. Yi Zhang*, Yi-Jie Ren, Ling-Chuan Guo, Cheng Ji, Jian Hu, Hong-Han Zhang,Qiong-Hua Xu, Wei-Dong Zhu, Zhi-Jun Ming, Yun-Sheng Yuan, Xingcong Ren, Jianxun, Song, and Jin-Ming Yang*. Nucleus Accumbens-Associated Protein-1 Promotes Glycolysis and Survival of Hypoxic Tumor Cells via the HDAC4-HIF-1α Axis, Oncogene, 2017 Jul 20;36(29):4171-4181. *(Corresponding author) Evaluated in“F1000” by“Faculty Of 1000 Biology”
6. Yi-Jie Ren, Xiao-Hui Wang, Cheng Ji, Yi-Di Guan, Xian-Jiu Lu, Xian-Rong Liu,Hong-Han Zhang, Ling-Chuan Guo, Qiong-Hua Xu, Wei-Dong Zhu, Zhi-Jun Ming, Jin-Ming Yang, Yan Cheng, Yi Zhang*. Silencing of NAC1 Expression Induces Cancer Cells Oxidative Stress in Hypoxia and Potentiates the Therapeutic Activity of Elesclomol, Front. Pharmacol, 07 November 2017,00804.
7. Zhang Y*, Yang WQ, Zhu H, Zhou L, Ren YJ, Ren XC, Zhang L, Wang JR, Liu YB, Yang JM. Regulation of Autophagy by miR-30d Impacts Sensitivity of Anaplastic Thyroid Carcinoma to Cisplatin, Biochem Pharmacol,2014 Feb 15;87(4):562-70. *(Corresponding author)
8. Ren YJ, Zhang Y*. An update on RNA interference-mediated gene silencing in cancer therapy. Expert Opin Biol Ther, 2014 Nov;14(11):1581-92. *(Corresponding author)
9. Xiao-yuan Liu, Li Zhang, JianPing Wu, Lei Zhou, Yi-Jie Ren, Wei-Qiong Yang, Zi-Jun Ming, Bo Chen, Jianrong Wang, Yi Zhang* and Jin-Ming Yang*. Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma. PLoS One,2013 Nov 26;8(11):e81345. *(Corresponding author)
10. Zhang Y*, Yang JM*. Altered energy metabolism in cancer: An unique opportunity for therapeutic intervention. Cancer Biol Ther,2013 Feb 1; 14(2):81-9. (*Corresponding author)
11. Zhang Y, Cheng Y, Ren XC, Hori T, Huber-KeenerKJ, Zhang L, Yap KL, Liu D, Shantz L, Qin ZH, Zhang SP, Wang JR, Wang HG, Shih IM and Yang JM: Dysfunction of Nucleus Accumbens-1 Activates Cellular Senescence and Inhibits Tumor Cell Proliferation and Oncogenesis. Cancer Res,72(16): 4262-4275, 2012.
12. Zhang Y, Cheng Y, Ren XC, Zhang L, Yap KL, Wu H, Patel R, Liu DX, Qin ZH, Shih IM and Yang JM*: NAC1 Modulates Sensitivity of Ovarian Cancer Cells to Cisplatin via Altering the HMGB1-Mediated Autophagic Response. Oncogene, 31(8): 1055-1064, 2012.
13. Yang WQ, Zhang Y*. RNAi-mediated gene silencing in cancer therapy. Expert Opin Biol Ther, 2012 Nov; 12(11):1495-504. (Invited Review, *Corresponding author)
14. Zhang Y, Jay W. Yang, Xingcong Ren and Jin-Ming Yang. NAC1 and HMGB1 enter a partnership for manipulating autophagy. Autophagy,2011 Dec 1;7(12).
15. Zhang Y*, Cheng Y, Zhang L, Ren X, Huber-Keener KJ, Lee S, Yun J, Wang HG, Yang JM. Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression. Biochem Biophys Res Commun,2011 Oct 14; 414(1):129-34. (* Corresponding author)
16. Zhang Y#, Zhang L#, Liu XY, Qin ZH, Yang JM. Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells. Acta Pharmacol Sin,2011, Mar;32(3):361-7. (# contributed equally to this study)
17. Zhang Y*, Yang JM. The impact of cellular senescence in cancer therapy: is it true or not? Acta Pharmacol Sin,2011 Oct; 32(10):1199-207. (* Corresponding author)
18. Li Z, Wang Y, Fu C, Wang X, Wang JJ, Zhang Y, Zhou D, Zhao Y, Luo L, Ma H, Lu W, Zheng J, Zhang X. Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists. Eur J Med Chem, 2018 Apr 10;149:30-44.
19. Cheng Y, Ren X, Zhang Y, Shan Y, Huber-Keener KJ, Zhang L, Kimball SR, Harvey H, Jefferson LS, Yang JM. Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells. Autophagy, 2013 Feb 1;9(2):208-19.
20. Yan Cheng, Ugir Hossain Sk, Yi Zhang, Xingcong Ren, Li Zhang, Kathryn J. Huber-Keener, Yuan-Wan Sun, Jason Liao, Shantu Amin, Arun K. Sharma, and Jin-Ming Yang. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. PLoS One, 2012;7(4):e35104.
京公网安备 11010802027423号